Literature DB >> 5381845

Clinical evaluation of a new hypolipidemic drug, CIBA 13,437-Su.

G Hartmann, G Forster.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 5381845     DOI： 10.1016/s0368-1319(69)80011-6

Source DB:  PubMed          Journal:  J Atheroscler Res        ISSN： 0368-1319


× No keyword cloud information.
  5 in total

1.  Comparative studies on the action of the optical antipodes of the hypolipidaemic aryloxyalkanoic acid, CH 13,437, on liver enzymes of the rat.

Authors:  U Schacht; K Schmitt; E Granzer
Journal:  Experientia       Date:  1972-07-15

2.  The hypolipidemic effect of SU-13,437 in rats with natural endogenous hypertriglyceridemia.

Authors:  P H Lenz; A I Fleischman
Journal:  Lipids       Date:  1971-11       Impact factor: 1.880

3.  Effects of Su-13437, a new hypolipidemic drug, upon synthesis in vivo of hepatic and carcass total fatty acids and total cholesterol.

Authors:  R J Cenedella
Journal:  Lipids       Date:  1971-07       Impact factor: 1.880

4.  Chenodeoxycholic acid therapy for hypertriglyceridaemia in men.

Authors:  M C Bateson; D Maclean; J R Evans; I A Bouchier
Journal:  Br J Clin Pharmacol       Date:  1978-03       Impact factor: 4.335

5.  Structure, composition, physical properties, and turnover of proliferated peroxisomes. A study of the trophic effects of Su-13437 on rat liver.

Authors:  F Leighton; L Coloma; C Koenig
Journal:  J Cell Biol       Date:  1975-11       Impact factor: 10.539
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.